SOTIO Doses First Patient in AURELIO-04 Phase 2 Trial of SOT

SOTIO Doses First Patient in AURELIO-04 Phase 2 Trial of SOT101 in Combination with KEYTRUDA® (pembrolizumab)

SOTIO Doses First Patient in AURELIO-04 Phase 2 Trial of SOT101 in Combination with KEYTRUDA® (pembrolizumab)
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Czech Republic , United States , Switzerland , Richard Sachse , Peter Grell , Merck Co Inc , Merck Sharp Dohme , Masaryk Memorial Cancer Institute , Drug Development Of Gustave Roussy Cancer Center , Superagonist Technology , Chief Medical Officer , Managing Director , Inpatient Unit , Drug Development , Gustave Roussy Cancer Center , Merck Sharp ,